Stock analysts at Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Insulet in a research note ...
Highlights,Piper Sandler increased Insulet’s target price to $310, maintaining a positive rating.,Multiple financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback